Could a pill replace the CPAP machine for sleep apnea?
NCT ID NCT07635563
First seen Jun 27, 2026 · Last updated Aug 14, 2026 · Updated 4 times
Summary
This Phase 2 trial tests IHL-42X, a combination of two drugs (dronabinol and acetazolamide), in people with obstructive sleep apnea. The study aims to see if the drug can reduce the number of breathing pauses during sleep and improve daytime symptoms. Participants will receive different doses of IHL-42X or a placebo over several four-week periods. The goal is to find a safe and effective dose that could offer an alternative to current treatments like CPAP machines.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- IHL-42X (dronabinol and acetazolamide combination)
- What this could lead to
- If successful, this could offer a new medication option for people with obstructive sleep apnea, potentially reducing the need for CPAP machines.
- What could go wrong
- This is a Phase 2 trial with a small number of participants, so results may not apply to everyone. The drug may cause side effects or prove no better than placebo.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for OBSTRUCTIVE SLEEP APNEA (OSA) are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
CNS Healthcare - Jacksonville
NOT_YET_RECRUITINGJacksonville, Florida, 32256, United States
-
CNS Healthcare - Memphis
NOT_YET_RECRUITINGMemphis, Tennessee, 38119, United States
-
CNS Healthcare Orlando
NOT_YET_RECRUITINGOrlando, Florida, 32801, United States
-
CTI Clinical Research Center
RECRUITINGCincinnati, Ohio, 45212, United States
-
Conquest Research/Neurotrials
NOT_YET_RECRUITINGWinter Park, Florida, 32789, United States
-
Exalt Clinical Research
NOT_YET_RECRUITINGChula Vista, California, 91910, United States
-
FutureSearch Trials of Dallas
NOT_YET_RECRUITINGDallas, Texas, 75251, United States
-
Intrepid Research
NOT_YET_RECRUITINGCincinnati, Ohio, 45245, United States
-
Palm Beach Research Center
RECRUITINGWest Palm Beach, Florida, 33409, United States
-
Sleep Therapy & Research Center
RECRUITINGSan Antonio, Texas, 78229, United States
-
Tandem Clinical Research
NOT_YET_RECRUITINGMarrero, Louisiana, 70072, United States
-
Teradan Clinical Trials LLC
RECRUITINGBrandon, Florida, 33511, United States
-
Velocity Clinical Research, Anderson
RECRUITINGAnderson, South Carolina, 29621, United States
-
Velocity Clinical Research, Rockville
NOT_YET_RECRUITINGRockville, Maryland, 20854, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Could a home sleep test beat the hospital for diagnosing apnea?
- A dual sleep disorder: can one pill boost CPAP success?
- What lies beneath sleep apnea? a deep dive into its hidden health ties
- Can a simple questionnaire spot hidden sleep apnea in millions?
- Wall squats tested as a blood pressure hack for sleep apnea patients
- Blood tests may one day replace sleep studies for apnea